High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer

por Onaga, Chotaro, Tamori, Shoma, Matsuoka, Izumi, Ozaki, Ayaka, Motomura, Hitomi, Nagashima, Yuka, Sato, Tsugumichi, Sato, Keiko, Xiong, Yuyun, Sasaki, Kazunori, Ohno, Shigeo, Akimoto, Kazunori
Publicado 2022

High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients

por Nozaki, Yuka, Motomura, Hitomi, Tamori, Shoma, Kimura, Yumiko, Onaga, Chotaro, Kanai, Shotaro, Ishihara, Yuka, Ozaki, Ayaka, Hara, Yasushi, Harada, Yohsuke, Mano, Yasunari, Sato, Tsugumichi, Sato, Keiko, Sasaki, Kazunori, Ishiguro, Hitoshi, Ohno, Shigeo, Akimoto, Kazunori
Publicado 2020

Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer

por Motomura, Hitomi, Ozaki, Ayaka, Tamori, Shoma, Onaga, Chotaro, Nozaki, Yuka, Waki, Yuko, Takasawa, Ryoko, Yoshizawa, Kazumi, Mano, Yasunari, Sato, Tsugumichi, Sasaki, Kazunori, Ishiguro, Hitoshi, Miyagi, Yohei, Nagashima, Yoji, Yamamoto, Kouji, Sato, Keiko, Hanawa, Takehisa, Tanuma, Sei-Ichi, Ohno, Shigeo, Akimoto, Kazunori
Publicado 2021